Skip to main content

Day: March 10, 2026

FBS Global Limited Engages Crescendo Communications for Investor Relations Services

Singapore, March 10, 2026 (GLOBE NEWSWIRE) — FBS Global Limited (Nasdaq: FBGL) (“FBS” or the “Company”), a green building contractor and interior fit-out specialist with more than 30 years of operating history, today announced that it has engaged Crescendo Communications, LLC, a New York-based strategic advisory firm, to provide investor relations services and support the Company’s capital markets communications strategy. Under the engagement, Crescendo Communications will work with FBS Global’s management team to enhance communication with institutional investors, research analysts and the broader investment community. The engagement will focus on strengthening market visibility, supporting investor outreach initiatives and assisting with strategic messaging around the Company’s operational execution and long-term growth objectives. Kelvin...

Continue reading

Worthington Enterprises Schedules Fiscal Third Quarter 2026 Earnings Call for March 25

COLUMBUS, Ohio, March 10, 2026 (GLOBE NEWSWIRE) — Worthington Enterprises Inc. (NYSE: WOR) will hold its quarterly earnings conference call Wednesday, March 25 at 8:30 a.m. ET. The company will discuss its fiscal third quarter results, which will be released after the market closes Tuesday, March 24. Please click here to register for the March 25 live audio webcast or visit IR.worthingtonenterprises.com. For those unable to listen live, a replay will be available in the Investors section of the company’s website approximately two hours after the completion of the call and will be archived for one year.   LIVE CONFERENCE CALL DETAILSDate:  Wednesday, March 25, 2026Webcast Link: https://events.q4inc.com/attendee/999794906Starting Time:  8:30 a.m. ETConference ID: 1777337Domestic Participants:  888-330-3567   About...

Continue reading

Lead Real Estate Co., Ltd Announces Delivery of EXCELSIOR NAKAMEGURO in Tokyo

TOKYO, March 10, 2026 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE” or the “Company”), a Japanese real estate developer of residential properties across Tokyo, Kanagawa Prefecture and Sapporo, today announced that it executed a sales contract for its income-producing condominium property, EXCELSIOR NAKAMEGURO, on February 17, 2026. The Company completed the delivery of the property on February 27, 2026. EXCELSIOR NAKAMEGURO is a 10-unit reinforced concrete condominium located in Kamimeguro, Meguro, Tokyo. The property consists of three floors above ground, with a building area of approximately 4,667 square feet and a land area of approximately 2,805 square feet.Actual Completed ExteriorActual Completed Interior Mr. Eiji Nagahara, Chief Executive Officer of Lead Real Estate Co., Ltd, commented: “The sale...

Continue reading

Rackspace and Uniphore Announce Strategic Partnership to Define a New Category of Infrastructure-to-Agents Architecture Accelerating Enterprise AI Adoption

SAN ANTONIO, March 10, 2026 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading hybrid multicloud and AI solutions company, today announced a strategic partnership with Uniphore, the Business AI leader backed by NVIDIA and AMD, to deliver the industry’s first Infrastructure-to-Agents architecture, offered as an outcomes-based service. The partnership reflects a shared ambition to unlock $100 million in enterprise AI deployments as customers move from AI experimentation to production at scale, without sacrificing governance, security, or control. This is especially relevant for regulated industries where choice, security and sovereignty are non-negotiable requirements. Operationalizing AI in production remains a challenge due to the complexity of choices across the stack. By integrating Uniphore’s Business AI...

Continue reading

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Recent Highlights:Fourth quarter revenue of $2.4 million, a 4% increase compared to the prior-year quarter and 9% increase sequentially. 208% increase in U.S. console sales in Q4 versus prior year quarter. Heart Failure revenue increased 48% and Pediatrics increased 16% year-over-year in Q4. Gross margin of 68.2% in Q4, compared to 58.4% in the prior-year quarter. Closed a $5.0 million private placement and warrant inducement transaction in January 2026, strengthening the Company’s capital position. Appointed Carisa Schultz as Chief...

Continue reading

Summit Royalties Announces Grant of Restricted Share Units

TORONTO, March 10, 2026 (GLOBE NEWSWIRE) — Summit Royalties Ltd. (TSXV: SUM, OTCQB: SUMMF) (the “Corporation” or “Summit”) announces that it has granted an aggregate of 350,000 restricted share units of the Corporation (“RSUs”) to certain senior officers of the Corporation pursuant to its omnibus incentive plan (the “Plan”). Of the 350,000 RSUs, 175,000 RSUs are scheduled to vest on March 9, 2027 and the remaining 175,000 RSUs are scheduled to vest on March 9, 2028. Once vested, each RSU represents the right to receive one common share in the capital of the Corporation per RSU held, a cash amount equivalent, or a combination thereof, in each case subject to the terms and conditions of the Plan and the applicable RSU agreement. About Summit Royalties Ltd. Summit Royalties Ltd. is a...

Continue reading

Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform 

 – Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization   – Anticipating initiation of pivotal clinical trial in 2026   – Updated electronics architecture delivers significant improvement in glucose measurement accuracy, with a material reduction in MARD across multi-day wear   – Multimodal sensing platform powered by advanced AI-native analytics to deliver personalized metabolic health insights   – CGM+ next-generation modular device architecture designed to reduce cost and improve sustainability versus current market-leading CGMs  – Company is positioning device to participate in fast-growing $15bn CGM market and adjacent sectors DUBLIN and WILSONVILLE, Ore., March 10, 2026 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage...

Continue reading

Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study

Raanana, Israel, March 10, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of a Good Manufacturing Practice (GMP) batch of clinical trial material (CTM) for its lead product candidate. This milestone follows the Company’s previously announced manufacturing agreement with Eurofins CDMO AmatsiAquitaine S.A.S, a leading global GMP CDMO, established to support the supply of clinical trial material for Polyrizon’s clinical development program. The GMP manufacturing milestone represents a key step in Polyrizon’s clinical development program and supports the company’s preparations for a planned clinical study in the United States later this year. The GMP batch was manufactured...

Continue reading

Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026

ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES10 MARCH 2026 at 13.50 EET          Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026 In accordance with a decision by the Board of Directors, Orion Corporation has on 10 March 2026 transferred altogether 172,778 Orion Corporation B shares held by the company as a share reward for earning period 2023–2025 and a reward for commitment part to the persons belonging to the Share-based Incentive Plan of Orion Group. The transfer is based on the authorisation by the Annual General Meeting of 23 March 2022. After the share transfer, the total number of own B shares held by Orion Corporation is 268,166. Orion Corporation has informed about the Share-based Incentive Plan in stock exchange release on 10 February 2022. Orion CorporationLiisa Hurme President...

Continue reading

Archimedes Tech SPAC Partners III Co. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing March 16, 2026

CLAYMONT, DE, March 10, 2026 (GLOBE NEWSWIRE) — Archimedes Tech SPAC Partners III Co. (Nasdaq: ARCIU) (the “Company”) today announced that, commencing March 16, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The ordinary shares and warrants that are separated will trade on The Nasdaq Global Market under the symbols “ARCI” and “ARCIW,” respectively. Those units not separated will continue to trade on The Nasdaq Global Market under the symbol “ARCIU.” Holders of units will need to have their brokers contact Odyssey Transfer and Trust Company, the Company’s transfer agent, in order to separate the units into ordinary...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.